AXSM:NASDAQ
Axsome Therapeutics Inc
$211.12
arrow_upward
+0.23%(+0.49) 1D
$211.12
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AXSM...
Open
$210.63
High
$211.65
Low
$208.01
Mkt. cap
11.06B
Avg. vol.
638.51K
Volume
0.00
52-wk high
$260.19
52-wk low
$112.90
EPS
-$3.76
Beta
0.71
Shares outstanding
52.38M
No. of employees
1K
Open
$210.63
High
$211.65
Low
$208.01
Mkt. cap
11.06B
Avg. vol.
638.51K
Volume
0.00
52-wk high
$260.19
52-wk low
$112.90
EPS
-$3.76
Beta
0.71
Shares outstanding
52.38M
No. of employees
1K
News stories
From web sources and news partners
Investing.com
·
12 hours ago
Axsome at cantor healthcare conference: auvelity growth accelerates
TradingView
·
12 hours ago
AXSM: AUVELITY's rapid growth and robust CNS pipeline position the company for significant expansion
The Motley Fool
·
13 hours ago
Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Simply Wall Street
·
13 hours ago
Axsome Therapeutics (AXSM) Starts Phase 3 SUMMIT Trial, Is The Upside Already Priced In?
About Axsome Therapeutics Inc
CEOHerriot Tabuteau
Employees1.35K
Founded2012
Headquarters-
SectorPharmaceutical industry
Websiteaxsome.com